ZOE.L Regulatory News (ZOE)

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF REGULATION 11 OF THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS 2019/310

Zoetic International plc

('Zoetic', the 'Company' or the 'Group')

Exercise of Share Options

Further to the announcement issued on 29 May 2020, Zoetic International plc (LSE: ZOE), the international CBD group, is pleased to announce that it has today issued 1,000,000 ordinary shares of 1 pence each ("Ordinary Shares") following the exercise of options, at an exercise price of 12 pence per Ordinary Share (the "Option Shares").

Application will be made to the London Stock Exchange for the Option Shares to be admitted to trading on the Main Market of the London Stock Exchange and the Standard Segment of the FCA Official List ("Admission"). It is expected that Admission will become effective and that dealings in the Option Shares on the Main Market of the London Stock Exchange will commence on or around 30 March 2021.

On Admission, the Company will have 196,570,034 Ordinary Shares in issue, each with one voting right. There are no shares held in treasury. Therefore, the Company's total number of Ordinary Shares and voting rights will be 196,570,034 and this figure may be used by shareholders from Admission as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

- Ends -

Publication on website

A copy of this announcement is also available on the Group's website at www.zoeticinternational.com

Media enquiries: